To investigate the mechanisms underlying the biological functions of USP13 in prostate cancer, differentially expressed genes (DEGs) were analyzed between PCa tumor tissues with high or low expression level of USP13 (separated by the median expression level of USP13) from the TCGA database (Fig. 4A). This evidence concerns the gene USP13 and prostate cancer.